1. Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
    Toshinori Ozaki et al, 2018, BMC Cancer CrossRef
  2. Discovery of small-molecule inhibitors of RUVBL1/2 ATPase
    Gang Zhang et al, 2022, Bioorganic & Medicinal Chemistry CrossRef
  3. Discovery of New Membrane-Associated Proteins Overexpressed in Small-Cell Lung Cancer
    Sebahat Ocak et al, 2014, Journal of Thoracic Oncology CrossRef
  4. Telomerase and Telomeres in Endometrial Cancer
    Rafah A. A. Alnafakh et al, 2019, Frontiers in Oncology CrossRef
  5. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling
    Junxin Chen et al, 2019, Molecular Cancer CrossRef
  6. CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity
    Victoria A. Assimon et al, 2019, ACS Chemical Biology CrossRef
  7. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC)
    Camila Baldin Storti et al, 2020, Experimental and Molecular Pathology CrossRef
  8. Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53
    Yong Tae Ahn et al, 2020, Marine Drugs CrossRef
  9. Downregulation of RUVBL1 inhibits proliferation of lung adenocarcinoma cells by G1/S phase cell cycle arrest via multiple mechanisms
    Xiao-Shuai Yuan et al, 2016, Tumor Biology CrossRef
  10. AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report
    Jan-Henrik Mikesch et al, 2018, Cellular Oncology CrossRef
  11. Deregulated levels of RUVBL1 induce transcription-dependent replication stress
    Rossitsa H. Hristova et al, 2020, The International Journal of Biochemistry & Cell Biology CrossRef
  12. Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma
    Yongfa Zeng et al, 2022, Disease Markers CrossRef
  13. Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients’ Survival
    Xiang Zhang et al, 2015, PLOS ONE CrossRef
  14. Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53
    Y Zhao et al, 2015, Cell Death & Differentiation CrossRef
  15. Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway
    Fengbo Tan et al, 2015, Journal of Experimental & Clinical Cancer Research CrossRef
  16. The Role of Pontin and Reptin in Cellular Physiology and Cancer Etiology
    Yu-Qian Mao et al, 2017, Frontiers in Molecular Biosciences CrossRef
  17. Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer
    Haoran Li et al, 2019, Carcinogenesis CrossRef
  18. Astaxanthin Modulates Apoptotic Molecules to Induce Death of SKBR3 Breast Cancer Cells
    Min Sung Kim et al, 2020, Marine Drugs CrossRef
  19. R2TP/PAQosome as a promising chemotherapeutic target in cancer
    Yoshito Kakihara et al, 2020, Japanese Dental Science Review CrossRef
  20. Rvb1/Rvb2 proteins couple transcription and translation during glucose starvation
    Yang S Chen et al, 2022, eLife CrossRef
  21. The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
    Nesrin Hasan et al, 2019, Cancers CrossRef